ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $125,000 | -41.3% | 57,768 | -5.0% | 0.06% | -37.5% |
| Q2 2021 | $213,000 | +0.9% | 60,785 | +183.5% | 0.09% | -1.1% |
| Q1 2021 | $211,000 | -7.5% | 21,443 | +1.8% | 0.09% | -6.3% |
| Q4 2020 | $228,000 | +53.0% | 21,057 | +45.7% | 0.10% | +21.8% |
| Q3 2020 | $149,000 | -56.6% | 14,457 | -12.0% | 0.08% | -51.9% |
| Q2 2020 | $343,000 | +3.0% | 16,434 | -51.8% | 0.16% | +18.2% |
| Q1 2020 | $333,000 | -26.0% | 34,113 | -12.7% | 0.14% | +85.1% |
| Q4 2019 | $450,000 | +254.3% | 39,082 | +67.4% | 0.07% | +184.6% |
| Q3 2019 | $127,000 | -56.7% | 23,351 | -5.3% | 0.03% | -58.1% |
| Q2 2019 | $293,000 | -41.6% | 24,652 | -70.3% | 0.06% | +19.2% |
| Q3 2018 | $502,000 | -34.2% | 82,998 | -42.3% | 0.05% | -92.3% |
| Q2 2018 | $763,000 | – | 143,951 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,109,867 | $42,332,000 | 29.76% |
| Versant Venture Management, LLC | 7,003,892 | $72,140,000 | 13.20% |
| Ghost Tree Capital, LLC | 1,161,375 | $11,962,000 | 3.46% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,944,000 | 2.54% |
| Soleus Capital Management, L.P. | 364,349 | $3,753,000 | 1.99% |
| RTW INVESTMENTS, LP | 7,234,764 | $74,518,000 | 1.79% |
| RA Capital Management | 9,410,860 | $96,932,000 | 1.77% |
| FRAZIER MANAGEMENT LLC | 1,437,028 | $14,801,000 | 1.33% |
| Casdin Capital, LLC | 2,750,000 | $28,325,000 | 1.27% |
| Avoro Capital Advisors LLC | 8,000,000 | $82,400,000 | 1.17% |